Chemical Collective

Unraveling Neuroinflammation: Dr. Kendra McLaughlin on Microglia, Biomarkers, and Innovative Therapies for Brain Health

28 min · 6 nov 2024
aflevering Unraveling Neuroinflammation: Dr. Kendra McLaughlin on Microglia, Biomarkers, and Innovative Therapies for Brain Health artwork

Beschrijving

Dr. Kendra McLaughlin, an assistant professor at UNLV, discusses her research on neuroinflammation and microglia, immune cells in the brain. She explains how microglia, which can protect neurons, can also become overactive and harmful under chronic stress or disease, contributing to neurodegenerative conditions like Alzheimer's and Parkinson's. Dr. McLaughlin highlights the importance of early detection through biomarkers and innovative therapies, such as TSPO modulators and cannabinoid-based treatments targeting CB2 receptors. She emphasizes the need for interdisciplinary approaches, including engineering models, to better understand and manage neuroinflammation, aiming for personalized medicine and early intervention to mitigate brain damage.

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de Chemical Collective community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

23 afleveringen

aflevering Unraveling Neuroinflammation: Dr. Kendra McLaughlin on Microglia, Biomarkers, and Innovative Therapies for Brain Health artwork

Unraveling Neuroinflammation: Dr. Kendra McLaughlin on Microglia, Biomarkers, and Innovative Therapies for Brain Health

Dr. Kendra McLaughlin, an assistant professor at UNLV, discusses her research on neuroinflammation and microglia, immune cells in the brain. She explains how microglia, which can protect neurons, can also become overactive and harmful under chronic stress or disease, contributing to neurodegenerative conditions like Alzheimer's and Parkinson's. Dr. McLaughlin highlights the importance of early detection through biomarkers and innovative therapies, such as TSPO modulators and cannabinoid-based treatments targeting CB2 receptors. She emphasizes the need for interdisciplinary approaches, including engineering models, to better understand and manage neuroinflammation, aiming for personalized medicine and early intervention to mitigate brain damage.

6 nov 202428 min